Profile
BSX-PA ABT BSX SYK MDT EW
Company Name Boston Scientific Corporation Abbott Laboratories Boston Scientific Corporation Stryker Corporation Medtronic plc Edwards Lifesciences Corporation
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $175.45B $239.05B $154.29B $143.53B $110.15B $44.08B
Employees 45.00K 114.00K 53.00K 53.00K 95.00K 15.80K
CEO Mr. Michael F. Mahoney Robert B. Ford Michael F. Mahoney Mr. Kevin A. Lobo Geoffrey Straub Martha Mr. Bernard J. Zovighian
Ratings
BSX-PA ABT BSX SYK MDT EW
Quant Rating Score 4 3 3 3 1
Quant Rating Buy Neutral Neutral Neutral Strong Sell
Trading
BSX-PA ABT BSX SYK MDT EW
Last Close $122.18 $137.4 $104.29 $392.23 $85.97 $76.97
High 52 $122.18 $140.22 $106.66 $399.9 $94.5 $93.78
Low 52 $122.18 $100.07 $72.96 $315.94 $76.84 $59.7
Price vs. 52 Week High 0 % -2.01 % -2.22 % -1.92 % -9.03 % -17.92 %
Price vs. 52 Week Low 0 % 37.3 % 42.94 % 24.15 % 11.88 % 28.93 %
Total Return
BSX-PA ABT BSX SYK MDT EW
1 Month Return 0 % 4.65 % -0.2 % 4.14 % 6.56 % 2.64 %
3 Month Return 0 % 8.52 % 1.91 % 6.65 % -2.56 % 8.27 %
6 Month Return 0 % 19.2 % 14.04 % 6.17 % 5.36 % 1.38 %
9 Month Return 0 % 21.88 % 25.53 % 8.55 % -3.89 % 17.03 %
YTD Return 0 % 21.47 % 16.76 % 8.94 % 7.62 % 3.97 %
1 Year Return 0 % 31.01 % 35.27 % 15.19 % 7.4 % -15.93 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BSX-PA ABT BSX SYK MDT EW
Dividend Yield Percentage (TTM) - 1.66 % - 0.87 % 3.26 % -
Dividend Paid and Capex Coverage Ration (TTM) 3.96 % 1.57 % 3.96 % 2.2 % 1.29 % 2.15 %
Dividend Per Share (TTM) - 2.28 % - 3.28 % 2.8 % -
Payout Ratio (TTM) 1.13 % 28.92 % 1.13 % 43.2 % 76.97 % -
Profitability
BSX-PA ABT BSX SYK MDT EW
Gross Profit Margin TTM 67.15 % 55.89 % 67.15 % 63.57 % 64.06 % 79.18 %
Return on Assets TTM 5.06 % 16.58 % 5.06 % 6.21 % 5.09 % 32.02 %
Return on Equity TTM 9.56 % 30.76 % 9.56 % 10.73 % 9.62 % 49.04 %
Return on Capital Employed TTM 8.77 % 10.5 % 8.77 % 9.61 % 7.56 % 12.83 %
Net Income Per EBT TTM 81.97 % 183.58 % 81.97 % 85.78 % 82.85 % 259.12 %
EBT Per Ebit TTM 80.59 % 102.35 % 80.59 % 91.04 % 94.51 % 108.9 %
EBIT Per Revenue TTM 17.52 % 16.97 % 17.52 % 15.77 % 17.76 % 26.75 %
Cash Flow To Debt Ratio TTM 32.56 % 67.59 % 32.56 % 29.81 % 24.7 % 77.47 %
Receivables Turnover TTM 6.52 4.38 6.52 5.86 5.15 7.61
Payables Turnover TTM 5.74 4.43 5.74 - 4.74 5.84
Inventory Turnover TTM 2.01 2.81 2.01 1.66 2.12 1.06
Fixed Asset Turnover TTM 517.94 % 387.34 % 517.94 % 656.62 % 490.52 % 310.44 %
Asset Turnover TTM 43.73 % 51.99 % 43.73 % 50.47 % 36.58 % 42.43 %
Operating Cash Flow Per Share TTM 2.58 5.12 2.58 11.23 5.49 0.92
Free Cash Flow Per Share TTM 1.94 3.81 1.94 9.37 4.04 0.49
Cash Per Share TTM 49.08 % 391.71 % 49.08 % 631.12 % 699.13 % 677.44 %
Operating Cash Flow Sales Ratio TTM 21.72 % 21.14 % 21.72 % 18.47 % 21 % 9.79 %
Free Cash Flow Operating Cash Flow Ratio TTM 75.37 % 74.38 % 75.37 % 83.42 % 73.61 % 53.46 %
Cash Flow Coverage Ratios TTM 32.56 % 67.59 % 32.56 % 29.81 % 24.7 % 77.47 %
Price To Free Cash Flows Ratio TTM 53.62 35.91 53.7 40.12 21.24 152.06
Price To Operating Cash Flows Ratio TTM 40.35 26.82 40.41 33.43 15.65 81.33
Price Cash Flow Ratio TTM 40.35 26.82 40.41 33.43 15.65 81.33
Income Statement (TTM)
BSX-PA ABT BSX SYK MDT EW
Revenue $16.75B $41.95B $16.75B $22.6B $33.54B $5.44B
Gross Profit $11.49B $23.24B $11.49B $14.44B $21.97B $4.32B
Gross Profit Ratio 68.61% 55.41% 68.61% 63.91% 65.51% 79.46%
EBITDA $3.94B $10.83B $3.94B $5.72B $5.96B $1.72B
Net Income $1.85B $13.4B $1.85B $2.99B $4.66B $4.17B
EPS Diluted 1.25 7.64 1.25 7.76 3.61 6.97
Balance Sheet (MRQ)
BSX-PA ABT BSX SYK MDT EW
Long Term Debt $8.84B $13.52B $8.84B $12.19B $25.64B $0.68B
Total Liabilities $17.39B $33.51B $17.39B $22.34B $43.42B $2.99B
Total Equity $22B $47.9B $22B $20.63B $48.26B $10.06B
Total Investments $0.56B $1.24B $0.56B $0.84B $6.75B $1.24B
Total Debt $11.15B $15.02B $11.15B $13.6B $28.52B $0.7B
Total Assets $39.4B $81.41B $39.4B $42.97B $91.68B $13.06B
Cash Flow Statement (TTM)
BSX-PA ABT BSX SYK MDT EW
Net Income $1.85B $13.4B $1.85B $2.99B $4.69B $4.17B
Inventory $-0.23B $-0.06B $-0.23B $0.05B $-0.29B $-0.26B
Dividends Paid $0B $-3.84B $0B $-1.22B $-3.59B $0B
Operating Cash Flow $3.44B $8.56B $3.44B $4.24B $7.04B $0.54B
Capital Expenditure $-0.79B $-2.21B $-0.79B $-0.76B $-1.86B $-0.25B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 133.69
ADGM Adagio Medical Holdings, Inc. 1.24
AEMD Aethlon Medical, Inc. 1.86
AFIB Acutus Medical, Inc. 0.0018
AHCO AdaptHealth Corp. 9.415
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 187.83
ALUR Allurion Technologies Inc. 2.49
AMIX Autonomix Medical, Inc. Common Stock 1.24
ANIK Anika Therapeutics, Inc. 10.84
AORT Artivion, Inc. 30.58
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.215
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 10.89
AVNS Avanos Medical, Inc. 12.15
AVR Anteris Technologies Global Corp. Common Stock 4
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 10.485
Unlock